# Ketorolac on Posterior Thoracolumbar Spinal Fusions

> **NCT03278691** · PHASE4 · UNKNOWN · sponsor: **Henry Ford Health System** · enrollment: 600 (estimated)

## Conditions studied

- Thoracolumbar Spinal Fusions

## Interventions

- **DRUG:** Saline
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT03278691
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-03
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278691, "Ketorolac on Posterior Thoracolumbar Spinal Fusions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03278691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*